Feasibility and Safety of Acupuncture for Systemic Lupus
Not Applicable
Completed
- Conditions
- Systemic Lupus Erythematosus
- Registration Number
- NCT00493753
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
The aim of this pilot study was to evaluate whether acupuncture is safe and acceptable to people with systemic lupus erythematosus (SLE). Twenty-four SLE patients were assigned randomly to receive either 10 sessions of acupuncture, 10 sessions of a minimal-needling control intervention, or their usual medical care alone. It was hypothesized that acupuncture would be safe for people with SLE, and that participants would be able to complete their assigned treatment within 5 to 6 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- diagnosed with SLE, 18 years old or older, pain duration at least 3 times per week for at least 3 months, medications and doses stable for the past month, able to speak, read, and understand English, and provide informed consent.
Read More
Exclusion Criteria
- known pregnancy, active uncontrolled organ involvement, steroid dose greater than 10 mg per day, platelets < 100,000, previous course of acupuncture treatment.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Safety (side effect and adverse event rates), protocol adherence (expected 80% of sessions completed on time) 6 weeks
- Secondary Outcome Measures
Name Time Method pre-post treatment effect size estimates for self-reported pain and fatigue 6 weeks
Trial Locations
- Locations (2)
UPMC Shadyside Center for Integrative Medicine
🇺🇸Pittsburgh, Pennsylvania, United States
UPMC General Clinical Research Center
🇺🇸Pittsburgh, Pennsylvania, United States